Brain Case Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Brain Case General Information

Description

Provider and developer of viral vectors and delivery strategies designed for small pharmaceutical and biotechnology companies. The company provides outsourced pharmaceutical research services of neurotropic virus, adeno-associated virus used in gene therapy and oncolytic virus, enabling clients to promote drug discovery and development process.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Floor 17, Building 4, Weiguang Life Science Park, Guangming New District
  • Shenzhen, Guangdong 518000
  • China
+86 189
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Floor 17, Building 4, Weiguang Life Science Park, Guangming New District
  • Shenzhen, Guangdong 518000
  • China
+86 189

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Brain Case Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 06-Sep-2022 Completed Clinical Trials - General
To view Brain Case’s complete valuation and funding history, request access »

Brain Case Patents

Brain Case Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10829784-B2 Method for preparing recombinant adeno-associated virus Active 20-Jan-2016
US-20180163228-A1 Method for preparing recombinant adeno-associated virus Active 20-Jan-2016
US-11180736-B2 Method of preparing recombinant adeno-associated virus and recombinant baculovirus Active 24-Dec-2015
US-20180155697-A1 Method of preparing recombinant adeno-associated virus and recombinant baculovirus Active 24-Dec-2015
US-10501758-B2 Recombinant baculovirus and method for using the same for preparing recombinant adeno-associated virus vector Active 23-Sep-2015 C12N15/86
To view Brain Case’s complete patent history, request access »

Brain Case Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Blue Horse Capital Venture Capital Minority
Shenzhen Zhongke Scientific Technological Equity Investment Fund Management Growth/Expansion Minority
To view Brain Case’s complete investors history, request access »

Brain Case FAQs

  • When was Brain Case founded?

    Brain Case was founded in 2020.

  • Where is Brain Case headquartered?

    Brain Case is headquartered in Shenzhen, China.

  • What industry is Brain Case in?

    Brain Case’s primary industry is Drug Discovery.

  • Is Brain Case a private or public company?

    Brain Case is a Private company.

  • What is Brain Case’s current revenue?

    The current revenue for Brain Case is .

  • Who are Brain Case’s investors?

    Blue Horse Capital and Shenzhen Zhongke Scientific Technological Equity Investment Fund Management have invested in Brain Case.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process